Sars-cov2 main protease inhibitors
US12410183B2 · kind B2 · utility
0Cited by
7References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2024 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Jun 14, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of Formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, useful in the treatment of treating viral infections, for example, coronaviridae infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.